Biogen chops expenses in Q2, raises 2022 profit forecast

Cost cutting helped Biogen beat second-quarter expectations soundly even as revenue slid and sales of the drugmaker’s controversial Alzheimer’s treatment collapsed. Aduhelm, a drug once expected to generate billions in annual sales, brought in only $100,000 in the quarter. That’s down from the $1.6 million in quarterly sales it recorded after hitting the market last…

Read More
Volkswagen To Develop New Semiconductor With STMicro Amid Chip Crunch

Volkswagen To Develop New Semiconductor With STMicro Amid Chip Crunch

By Mathieu Rosemain and Victoria Waldersee PARIS/BERLIN (Reuters) -Germany’s Volkswagen and Franco-Italian chipmaker STMicroelectronics will co-develop a new semiconductor amid a global microchip crunch that has strained the car industry’s supply chain, the companies said on Wednesday. The move illustrates how Volkswagen, Europe’s biggest carmaker, is striving to gain greater control over the supply of…

Read More